Sex differences in the prediction of neuroleptic response
It is currently not possible to accurately predict neuroleptic response. It is not known which acutely psychotic patients will respond to drugs with relative speed and comprehensiveness, or at low, as compared to standard doses. It is not known which patients will remain relapse-free over a given time period on maintenance neuroleptic therapy. It is not known which patients will sustain full, as distinct from partial, remission in response to maintenance drug therapy. It is not known which patients, after a stable period, will be able to undergo dose reductions without a return of symptoms or of dysfunction (Gaebel et al. 1987).
KeywordsSchizophrenic Patient Tardive Dyskinesia Neuroleptic Treatment Acute Dystonia BioI Psychiatry
Unable to display preview. Download preview PDF.
- Addington J, Addington D (1993) Premorbid functioning, cognitive functioning, symptoms, and outcome in schizophrenia. J Psychiatr Neurosci 18:18–23.Google Scholar
- Awad AG (1992) Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Commun Psychiatry 43:262–265.Google Scholar
- Corrigan PW, Liberman RP, Engel JD (1990) From noncompliance to collaboration in the treatment of schizophrenia. Hosp Commun Psychiatry 41:1203–1211.Google Scholar
- Dale R, Langdon M, Seeman MV (1994) Reducing the dose of depot neuroleptic in stable schizophrenia. J Psychiatr Neurosci 19 (in press).Google Scholar
- Inoue K, Nakajima T, Kato N (1986) A longitudinal study of schizophrenia in adolescence I. The one-to three-year outcome. Jpn J Psychiatr Neurol 40:143–151.Google Scholar
- Niznik H, Van Tol HHM (1992) Dopamine receptor genes: new tools for molecular psychiatry. J Psychiatr Neurosci 17:158–180.Google Scholar
- Pakaslahti A (1992) Prediction of working disability in schizophrenia: a 5-year prospective study of a representative cohort of first-admissons. Publications of the Social Insurance Institution, Finland, ML #119, 1–102.Google Scholar
- Seeman MV (1983a) Schizophrenic men and women require different treatment programs. J Psychiatr Treatment Evaluation 5:143–148.Google Scholar
- Seeman MV (1989) Prescribing neuroleptics for men and women. J Soc Pharmacol 3:219–236.Google Scholar
- Seeman MV (1994) The schizophrenic mother. In: Gopfert M, Webster J, Seeman MV (eds) Disturbed and mentally ill parents and their children. Cambridge University Press, Cambridge (in press).Google Scholar
- Toran-Allerand CD (1990) Interactions of estrogens with growth factors in the developing central nervous system. In: Hochberg RB, Naftolin F (eds) The new biology of steroid hormones. Raven Press, New York, pp 311–323.Google Scholar